Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trixéra is a topical emollient and skin-protective cream developed by Pierre Fabre under the Eau Thermale Avène brand. It is specifically formulated for the management of very dry, atopic, and sensitive skin. The product contains a combination of Avène Thermal Spring Water, which provides anti-irritant and soothing properties, and Selectiose (pentyl rhamnoside), a patented ingredient that helps reduce skin hypersensitivity and inflammation. Additionally, it includes a lipidic trio of ceramides, essential fatty acids, and plant sterols to restore the skin's protective barrier. In clinical settings, Trixéra has been evaluated as a supportive care intervention to prevent or mitigate radiation dermatitis in patients undergoing radiotherapy for breast cancer, aiming to maintain skin integrity and improve quality of life during treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Trixéra.